Prostate Single Port & Laser Enucleation Comparison Trial

Recruiting now · Not applicable

Conditions studied: Prostate Hyperplasia

In brief

Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.

Key facts

Study ID

NCT06224218

Run by

University of Illinois at Chicago

People needed

116

Starts

2024-01-15

Expected to finish

2027-08-15

Last updated by the study team

2024-05-16

Who can join

Age: 18 and older, up to 88. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with symptomatic Benign Prostatic Hyperplasia (BPH) who fail conservative treatment with drug therapy are eligible for surgical intervention.

You may not qualify if…

• Adults unable to consent Prisoners Cognitive impaired adults Coagulopathy

Where it is running

• UI Health SCB Clinic Department of Urology — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.